To Treat or Not To Treat, That Is The Question
There are no right or wrong answers for men with prostate cancer when trying to decide what treatment to have, or even if they want to have treatment. One vital piece of information that is [...]
An Official Release of the Exciting Results of the Abiraterone Acetate (Zytiga) Trial
Today’s big news is about a media release made yesterday by Centocor Ortho Biotech with the official and final results of the Phase III clinical trial of abiraterone acetate (Zytiga™) plus prednisone vs. prednisone alone [...]
Is Intermittent Androgen Suppression Becoming the New Standard in Recurrent Prostate Cancer?
Recent data presented at the 2011 Genitourinary Cancers Symposium supports the growing consensus that intermittent androgen suppression (IADT) is no less effective than continuous androgen suppression at treating men with prostate cancer that recurs after [...]
A Personal Request – Help Us Save The Prostate Cancer Research Program at the Department of Defense
U.S. SENATE: Save the Prostate Cancer Research Program Now it is time to write your U.S. Senators - TODAY! A few weeks ago I requested that you write to your member of the House of [...]
Surgery Improves Survival Rates for Men with Advanced Prostate Cancer
Researchers from the Mayo Clinic recently announced results at the American Urological Association (AUA) Annual Meeting from a long-term study that indicates that surgery can improve life expectancy for men with advanced prostate cancer. Their [...]
The Impact of the Setting on the Quality of Life for both Cancer Survivors and Caregivers When Death Comes
It is in the normal course of events that as our advanced prostate cancer progresses we will eventually end up dying from the disease. There will come a time when our doctors will no longer [...]